Schedule 13G ownership disclosure

NovaBay Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 66987P102

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,198,656
Percent of class
8.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-15-002368
Form type
SC 13G/A
Filer
Najafi Ramin
CIK
CIK 1410081
Filed
Feb 11, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub